Par Pharmaceutical – Clonazepam Orally Disintegrating Tablets, USP (C-IV)

← Back to Drug Recalls

Recall Category: Drug Recalls

Date: 11/19/2024

Brand: Par Pharmaceutical

Product: Clonazepam Orally Disintegrating Tablets, USP (C-IV)

Recall Reason: Mislabeled with the incorrect strength on the carton

Company: Endo, Inc.

Dosage Form: Tablet

Recall Issue Type: Labeling / Packaging

Terminated Recall: Terminated

View FDA Drug Recall Notice